Breaking News Instant updates and real-time market news.

PACB

Pacific Biosciences

$9.05

0.18 (2.03%)

, ILMN

Illumina

$184.85

0.36 (0.20%)

17:13
10/10/16
10/10
17:13
10/10/16
17:13

Pacific Biosciences down 4.4%, QIAGEN down 1.8% after Illumina warning

PACB

Pacific Biosciences

$9.05

0.18 (2.03%)

ILMN

Illumina

$184.85

0.36 (0.20%)

QGEN

QIAGEN

$27.57

0.19 (0.69%)

A

Agilent

$47.69

0.31 (0.65%)

  • 10

    Oct

  • 01

    Nov

PACB Pacific Biosciences
$9.05

0.18 (2.03%)

04/22/16
CANT
04/22/16
NO CHANGE
CANT
Pacific Biosciences should be bought after strong Q1 results, says Cantor
Cantor recommends that investors buy the shares of Pacific Biosciences after the company reported stronger than expected Q1 results. The firm thinks that the company's increased guidance may be conservative, and it believes that the company could have at least 30 bookings in Q2. Cantor keeps an $18 price target and Buy rating on the shares.
04/18/16
PIPR
04/18/16
NO CHANGE
Target $11
PIPR
Neutral
Pacific Biosciences estimates lowered on Sequel checks at Piper Jaffray
Piper Jaffray analyst William Quirk lowered his Q1 estimates for Pacific Biosciences after his initial round of Sequel channel checks found six placements during the quarter compared to the 17 he modeled. Assuming Roche placed five systems, the Q1 total would come to 11, Quirk tells investors in a research note. The analyst keeps a Neutral rating on the shares with an $11 price target.
08/04/16
08/04/16
NO CHANGE

On The Fly: After Hours Movers
UP AFTER EARNINGS: Pacific Biosciences (PACB), up 17%... MasTec (MTZ), up 9.6%... Aratana Therapeutics (PETX), up 9.2%... Lion's Gate (LGF), up 6.4%... Priceline (PCLN), up 5.7%... Ubiquiti (UBNT), up 5.5%... MercadoLibre (MELI), up 4.1%... Organovo (ONVO), up 3.9%... Kraft Heinz (KHC), up 3.3%... EOG Resources (EOG), up 2.8%... Monster Beverage (MNST), up 1.2%... TASER (TASR), up 1.2%... Take-Two (TTWO), up 0.9%... Activision Blizzard (ATVI), up 1%... BioMarin (BMRN), up 0.4%. ALSO HIGHER: Egalet (EGLT), up 31.2% after the company announced that an FDA advisory committee recommended approval of its ARYMO ER drug... Rackspace (RAX), up 17.6% after the Wall Street Journal reported that the company was near a takeover deal with a private equity buyer... Osiris (OSIR), up 8.5% after it said that the manuscript from its prospective trial using Grafix was published. DOWN AFTER EARNINGS: Hortonworks (HDP), down 26.2%... PDL BioPharma (PDLI), down 17.5%... FireEye (FEYE), down 15.8%... Sierra Wireless (SWIR), down 15.6%... Aquinox (AQXP), down 14.7%... Zynga (ZNGA), down 9.4%... Universal Display (OLED), down 8.2%... Weight Watchers (WTW), down 7.6%... Zillow Group (Z, ZG), down 5.5%... Arista Networks (ANET), down 4.5%... Noodles & Company (NDLS), down 4.3%... Merrimack (MACK), down 1.7%... Bankrate (RATE), down 1.7%.
08/18/16
CANT
08/18/16
NO CHANGE
Target $165
CANT
Speculative Buy
Thermo Fisher unlikely to acquire Illumina, says Cantor
Cantor Fitzgerald analyst Bryan Brokmeier believes it is unlikely that Thermo Fisher (TMO) will attempt to acquire Illumina (ILMN). Even if Thermo were to attempt a deal, the merger would be unlikely to close, Brokmeier tells investors in an intraday research note. If Illumina is a willing seller, however, Roche (RHHBY) may reconsider a bid, the analyst contends. He recommends investors stay on the sidelines with respect to Illumina shares. Brokmeier has a Hold rating on the name with a $165 price target. The analyst continues to believe Roche is the most likely acquirer of Pacific Biosciences (PACB).
ILMN Illumina
$184.85

0.36 (0.20%)

08/22/16
KING
08/22/16
DOWNGRADE
KING
Neutral
Illumina downgraded to Neutral from Buy at CL King
CL King analyst David Westenberg downgraded Illumina to Neutral given the recent run-up in the shares and lack of near-term visible catalysts.
08/18/16
WELS
08/18/16
NO CHANGE
WELS
Wells Fargo says Thermo Fisher buying Illumina 'makes no sense'
Wells Fargo analyst Tim Evans believes speculation of Thermo Fisher (TMO) acquiring Illumina "makes no sense." The analyst estimates the deal would be about 14% dilutive to Thermo in year one and "would struggle to be neutral" to earnings by year three. Further, the deal would run into "significant regulatory hurdles" since that Illumina holds a near monopoly in high-throughput sequencing, Evans tell investors note. Shares of Illumina are off their highs but remain up 3% after StreetInsider stoked renewed takeout speculation by citing a source saying Thermo may bid $30B for the company.
09/12/16
SBSH
09/12/16
NO CHANGE
Target $190
SBSH
Buy
Illumina price target raised to $190 from $175 at Citi
Citi analyst Daniel Arias raised his price target for Illumina to $190 after traveling with the company's CFO Marc Stapley and investor relations head Rebecca Chambers. The analyst believes the business "can hold its own" in the second half of 2016 and that shares can move higher in 2017. He keeps a Buy rating on Illumina.
QGEN QIAGEN
$27.57

0.19 (0.69%)

11/12/15
STFL
11/12/15
INITIATION
STFL
Hold
QIAGEN initiated with a Hold at Stifel
05/25/16
PIPR
05/25/16
NO CHANGE
PIPR
Neutral
Piper says QIAGEN may need to change or pull GeneReader if Illumina wins suit
Piper Jaffray analyst William Quirk said patent infringement outcomes are hard to predict, but added that Illumina's (ILMN) win at the Patent Trial and Appeal Board increase its chances to prevail in its recently filed infringement lawsuit against Qiagen (QGEN) related to the GeneReader DNA sequencer. If Illumina does win, Qiagen will need to "drastically" alter the product and/or remove it from the market, said Quirk, who keeps a Neutral rating on Qiagen shares.
08/01/16
HSBC
08/01/16
UPGRADE
HSBC
Buy
QIAGEN upgraded to Buy from Hold at HSBC
HSBC analyst Keppeler upgraded QIAGEN to Buy and increased its price target to $27 from $20. The analyst is more constructive on improving trends in Academia/Pharma and expects topline growth to accelerate to 7% in 2017 from 1-4% in 2012-2015 from strong growth drivers that include QiaSymphony instrument and the NGS franchise.
11/12/15
11/12/15
INITIATION

On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Accuray (ARAY) initiated with a Sell at Citi... Becton Dickinson (BDX) initiated with a Neutral at Citi... Boston Scientific (BSX) initiated with a Buy at Citi... Bruker (BRKR) initiated with a Buy at Stifel... C.R. Bard (BCR) initiated with a Buy at Citi... Cepheid (CPHD) initiated with a Buy at Stifel... CorMedix (CRMD) initiated with a Buy at Rodman & Renshaw... CoreSite Realty (COR) initiated with a Buy at BB&T... Digital Realty (DLR) initiated with a Buy at BB&T... DuPont Fabros (DFT) initiated with a Hold at BB&T... Duke Realty (DRE) initiated with a Hold at BB&T... Edwards Lifesciences (EW) initiated with a Sell at Citi... Electronic Arts (EA) initiated with an Outperform at Oppenheimer... EyeGate (EYEG) initiated with a Buy at Maxim... Glu Mobile (GLUU) initiated with a Perform at Oppenheimer... Integra LifeSciences (IART) initiated with a Buy at Citi... Intuitive Surgical (ISRG) initiated with a Buy at Citi... Mast Therapeutics (MSTX) initiated with a Buy at Maxim... Medgenics (MDGN) initiated with a Buy at Needham... Novocure (NVCR) initiated with a Buy at Evercore ISI... Prologis (PLD) initiated with a Hold at BB&T... QIAGEN (QGEN) initiated with a Hold at Stifel... Rocket Fuel (FUEL) initiated with a Neutral at Boenning & Scattergood... STAG Industrial (STAG) initiated with an Underweight at BB&T... Stryker (SYK) initiated with a Sell at Citi... Tremor Video (TRMR) initiated with an Outperform at Boenning & Scattergood... VOXX (VOXX) initiated with an Outperform at Oppenheimer... Varian Medical (VAR) initiated with a Neutral at Citi... Yahoo (YHOO) initiated with an Outperform at Boenning & Scattergood... YuMe (YUME) initiated with a Neutral at Boenning & Scattergood... Zimmer Biomet (ZBH) initiated with a Sell at Citi.
A Agilent
$47.69

0.31 (0.65%)

05/23/16
JANY
05/23/16
NO CHANGE
JANY
Buy
Janney says Thermo Fisher not buying Agilent, but names some other targets
In a note to investors published Friday afternoon, Janney Capital analyst Paul Knight said he was surprised that Thermo Fisher (TMO) said at its analyst day that it intends to spend at least 70% of deployed capital, or $12B over four years, on M&A, noting he expected more buybacks. Knight said Agilent (A) is often mentioned as a Thermo target, but he does not see that deal happening given the antitrust hurdles. Knight said Thermo is likely to acquire in the biological production space, where there are limited candidates, and noted that Repligen (RGEN) "possesses a near monopoly" in Protein A ligands. There are also "easy adds" in biological reagents, Knight tells investors, noting that Bio-Techne (TECH) is one of the two leading reagent companies for research proteins and antibodies. The firm has a Buy rating on Thermo Fisher shares.
05/17/16
EVER
05/17/16
NO CHANGE
Target $48
EVER
Buy
Agilent price target raised to $48 on strong Q2 print at Evercore ISI
Evercore ISI analyst Ross Muken raised Agilent's price target to $48 from $43 citing the strong Q2 report driven by HSD core revenue growth, solid OMx exeuction, and impressive uptick free cash flow, and the guidance raise. Muken has increased confidence in execution and upside to his forecasts, and reiterates his Buy rating.
05/17/16
JANY
05/17/16
NO CHANGE
Target $52
JANY
Buy
Agilent current quarter guidance looks conservative, says Janney Capital
Janney Capital analyst Paul Knight said Agilent's results beat expectations on "every line" in the April quarter and he believes the company's guidance for the current quarter looks conservative. Knight, who expects tailwinds as academia improves and China gains visibility, raised his fair value estimate on Agilent shares to $52 from $45 and keeps a Buy rating on the name.
05/25/16
LEER
05/25/16
NO CHANGE
LEER
Outperform
Agilent analyst day reinforces margin expansion opportunity, says Leerink
Leerink analyst Dan Leonard said today's analyst day meeting held by Agilent reinforced his view that the company has more margin expansion opportunity that is "top-line independent" than its peers in the Life Science Tools space. The company's articulation of an opportunity to reduce its effective tax rate by 200bps over the next two years was an unexpected "nice surprise," added Leonard, who keeps an Outperform rating on the stock.

TODAY'S FREE FLY STORIES

12:45
02/28/17
02/28
12:45
02/28/17
12:45
General news
Euro$ interest rate futures are above lows »

Euro$ interest rate…

XLF

Financial Select Sector

$24.39

-0.165 (-0.67%)

12:41
02/28/17
02/28
12:41
02/28/17
12:41
Options
Defensive short-term play opened in SPDR Financial ETF »

Defensive short-term play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$81.38

-0.1565 (-0.19%)

12:37
02/28/17
02/28
12:37
02/28/17
12:37
Syndicate
Exxon Mobil registers 68M shares of common stock related to private placement »

On January 16, 2017, an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

SYRX

Sysorex

$0.23

0.0066 (2.93%)

, INPX

Inpixon

12:35
02/28/17
02/28
12:35
02/28/17
12:35
Hot Stocks
Sysorex gets favorable listing decision, effects split, changes name to Inpixon »

Sysorex announced it has…

SYRX

Sysorex

$0.23

0.0066 (2.93%)

INPX

Inpixon

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$58.66

-8.2475 (-12.33%)

, CVI

CVR Energy

$22.87

0.72 (3.25%)

12:33
02/28/17
02/28
12:33
02/28/17
12:33
General news
On The Fly: Top stock stories at midday »

Stocks began the session…

TGT

Target

$58.66

-8.2475 (-12.33%)

CVI

CVR Energy

$22.87

0.72 (3.25%)

CVRR

CVR Refining

$11.40

0.55 (5.07%)

DK

Delek US

$24.76

1.78 (7.75%)

HFC

HollyFrontier

$29.48

0.9725 (3.41%)

PBF

PBF Energy

$24.62

1.18 (5.03%)

VLO

Valero

$69.32

2.08 (3.09%)

PCLN

Priceline

$1,632.01

0.39 (0.02%)

HTZ

Hertz

$21.54

1.54 (7.70%)

SBY

Silver Bay Realty

$21.49

3.315 (18.24%)

GME

GameStop

$25.17

-1.35 (-5.09%)

MSFT

Microsoft

$64.23

-0.39 (-0.60%)

VRX

Valeant

$15.07

-1.64 (-9.81%)

SIG

Signet Jewelers

$66.97

-5.91 (-8.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 02

    Mar

  • 02

    Mar

  • 09

    Mar

  • 14

    Mar

  • 14

    Mar

  • 19

    Mar

  • 09

    May

12:30
02/28/17
02/28
12:30
02/28/17
12:30
General news
Breaking General news story  »

Kansas City Federal…

MINI

Mobile Mini

$33.45

-0.35 (-1.04%)

12:28
02/28/17
02/28
12:28
02/28/17
12:28
Hot Stocks
Mobile Mini rebrands Evergreen Tank Solutions, Water Movers units »

Mobile Mini announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

ORBC

ORBCOMM

$8.18

0.06 (0.74%)

12:27
02/28/17
02/28
12:27
02/28/17
12:27
Hot Stocks
ORBCOMM says partner wins multi-year contract with Canada »

ORBCOMM announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

LIOX

Lionbridge

$5.75

0.01 (0.17%)

12:26
02/28/17
02/28
12:26
02/28/17
12:26
Hot Stocks
Lionbridge announces tockholder approval of HIG Capital acquisition »

Lionbridge Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

XOM

Exxon Mobil

$81.42

-0.125 (-0.15%)

12:25
02/28/17
02/28
12:25
02/28/17
12:25
Syndicate
Breaking Syndicate news story on Exxon Mobil »

Exxon Mobil files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

TV

Grupo Televisa

$25.73

-1.06 (-3.96%)

12:21
02/28/17
02/28
12:21
02/28/17
12:21
Options
Put seller opens a notable new position in Grupo Televisa »

Put seller opens a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHT

DHT Holdings

$4.66

-0.015 (-0.32%)

, FRO

Frontline

$6.92

0.19 (2.82%)

12:20
02/28/17
02/28
12:20
02/28/17
12:20
Hot Stocks
DHT says rejects revised Frontline bid, offers to meet with company »

DHT Holdings (DHT)…

DHT

DHT Holdings

$4.66

-0.015 (-0.32%)

FRO

Frontline

$6.92

0.19 (2.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 22

    Mar

SIG

Signet Jewelers

$66.85

-6.03 (-8.27%)

12:20
02/28/17
02/28
12:20
02/28/17
12:20
Hot Stocks
Breaking Hot Stocks news story on Signet Jewelers »

Signet Jewelers trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

SRAX

Social Reality

$2.58

-0.02 (-0.77%)

12:19
02/28/17
02/28
12:19
02/28/17
12:19
Hot Stocks
Breaking Hot Stocks news story on Social Reality »

Martin A. Sumichrast…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIG

Signet Jewelers

$66.85

-6.03 (-8.27%)

12:18
02/28/17
02/28
12:18
02/28/17
12:18
Hot Stocks
Breaking Hot Stocks news story on Signet Jewelers »

Signet Jewelers trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

$NSD

NASDAQ Market Internals

12:17
02/28/17
02/28
12:17
02/28/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
02/28/17
02/28
12:16
02/28/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$42.64

-0.43 (-1.00%)

12:07
02/28/17
02/28
12:07
02/28/17
12:07
Periodicals
PayPal sued over treatment of charity donations, CNBC reports »

PayPal has been sued in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 16

    Mar

  • 21

    Mar

  • 22

    Mar

  • 27

    Mar

  • 28

    Mar

ARTNA

Artesian Resources

$32.99

0.28 (0.86%)

12:04
02/28/17
02/28
12:04
02/28/17
12:04
Hot Stocks
Artesian Water agrees to acquire water assets of FDRPC »

Artesian Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGN

Align Technology

$102.26

-0.63 (-0.61%)

12:04
02/28/17
02/28
12:04
02/28/17
12:04
Recommendations
Align Technology analyst commentary  »

Align Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$11.32

-0.155 (-1.35%)

12:01
02/28/17
02/28
12:01
02/28/17
12:01
Options
Defensive option play opened in the US Oil Fund »

Defensive option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIG

Signet Jewelers

$66.85

-6.03 (-8.27%)

11:58
02/28/17
02/28
11:58
02/28/17
11:58
Hot Stocks
Signet's Sterling calls media reports 'distorted and inaccurate' »

Sterling Jewelers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

ACH

Aluminum Corp. of China

$12.44

-0.18 (-1.43%)

11:55
02/28/17
02/28
11:55
02/28/17
11:55
Upgrade
Aluminum Corp. of China rating change  »

Aluminum Corp. of China…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
02/28/17
02/28
11:55
02/28/17
11:55
General news
Treasury's bill auctions saw rather tepid results »

Treasury's bill…

P

Pandora

$12.59

-0.585 (-4.44%)

, LMCA

Liberty Media

11:54
02/28/17
02/28
11:54
02/28/17
11:54
Hot Stocks
Pandora lower after Liberty Media CEO comments on valuation »

Shares of Pandora Media…

P

Pandora

$12.59

-0.585 (-4.44%)

LMCA

Liberty Media

SIRI

Sirius XM

$5.18

0.06 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 06

    Mar

  • 19

    Mar

  • 22

    Mar

  • 23

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.